Revolutionizing Cell Culture: Automated Systems to Surpass US$20.87 Billion by 2030, growing at a 8.4% CAGR | FMI Report Unveils

The global Automated Cell Culture Systems Market is expected to grow at an 8.4% CAGR from US$ 10.91 billion in 2022 to US$ 20.87 billion by 2030. High-throughput screening technology has turned out to be the need of the hour, especially with large number of biological/chemical compounds being tested to target a particular ailment. As such, leveraging automation and robotics for quick testing of biochemical or biological activities is bound to drive the automated cell culture systems market.

Besides, 3D cell cultures, which were cumbersome and costly earlier, have become feasible, owing to advent of spheroids. Also, they imitate tumors better due to hypoxic core and presence of nutrient gradient.

Researchers in the US and Germany have come up with a protocol to grow 3D cultures of generally used cancer cells to facilitate drug screenings. These factors will continue to put North America and Europe at the top pedestal in the automated cell culture systems market.

Further, requirement of cell lines for devising vaccines against COVID-19 infection will augur well for the automated cell culture market in spite of the pandemic-induced economic downturn.

Grab a visually stunning report with related graphs and charts as a bonus. Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7860

Key Takeaways from Automated Cell Culture Systems Market

  • Consumables are expected to reach US$ 11 Bn by 2030
  • Academic institutes are expected to take greater interests in research related to cell culture over the forecast period due to increased government funding in developed countries
  • North America and Europe collectively accounted for more than 60% of market share in 2019
  • Infinite cell line cultures held close to 75% of market share in 2019

New Product Launches to Remain Key Strategic Focus of Market Players

Players in automated cell culture systems market are focusing on new product launches for expanding their global footprint and strengthening product portfolio.

For instance –

  • In Jun 2020, faCellitate announced launching “BIOFLOAT”, its very first product to improve 3D cell culture.
  • In Mar 2020, BioProcess International started implementing single-use miniature bioreactors for supporting intensified cell culture by using functional performance indicators for assessing small-scale model
  • Corning Incorporated, in Oct 2019, came up with Corning Elplasia Plates and Matrigel for organoid culture. It was an addition to its 3D cell culture portfolio
  • Ori Biotech has started developing an automated way of manufacturing cell and gene therapies
  • In May, 2020, Sartorius announced launch of the Incucyte SX5® for live-cell analysis, for live-cell analysis experiments

Uncover More Information by Clicking on the Provided Link Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-7860

Automated Cell Culture Systems Market: Competitive Insights

The global automated cell culture systems market is set to expand its scope in the forecast period, stimulated by increasing drug discovery research and diverse applications of cell lines in research purposes. Furthermore, automated cell culture systems are used for experiments in drug discovery research and in cell banking process. In addition, cost effectiveness and rise in alternative methods for traditional cell culture production is augmenting the adoption of automated cell culture systems.

Key market players covered in the market include Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza, Sartorius AG, Tecan Trading AG, Hamilton Medical AG., Biospherix and Promocell GmbH.  Key players integrate their positions through acquisitions, mergers and new product launches.

Key Segments of Automated Cell Culture Systems Industry Survey

Automated Cell Culture Systems Market by Product:

  • Automated Cell Culture Storage Equipment
  • Automated Cell Culture Vessels
  • Bioreactors
  • Consumables

Automated Cell Culture Systems Market by Cell Culture:

  • Finite Cell Line Cultures
  • Infinite Cell Line Cultures

Knowledge Unveiled: Ask the Expert, Learn with Confidence.  Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-7860

  • Automated Cell Culture Systems Market by Application:
  • Drug Development
  • Stem Cell Research
  • Regenerative Medicine
  • Cancer Research

Automated Cell Culture Systems Market by End User:

  • Biotech Companies
  • Research Organizations
  • Academic Institutes

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape:

Amniotic Membranes Market: The global amniotic membranes market size is likely to touch a valuation of around US$ 1.4 Bn in 2022. Further, with rising adoption of amniotic membranes for various purposes in ophthalmology, the total sales of amniotic membranes are slated to grow at an impressive CAGR of 9.0% between 2022 and 2028, totalling over US$ 2.3 Bn by the end of 2028.

Digital Radiography Detectors Market: The digital radiography detectors market is valued at US$ 2.13 Bn in 2022. The market is advancing at an average pace with a CAGR of 6.1% through 2026 to reach a valuation of US$ 2.7 Bn. The worldwide market for digital radiography detectors is highly concentrated, with large competitors such as Varex Imaging Corporation and Trixell accounting for about 47% of the market share.

Sepsis Diagnostics MarketThe global sepsis diagnostics market is expected to record a CAGR of 8.1% between 2023 and 2033. In 2023, the market is estimated to be valued at US$ 561.2 million. The valuation is expected to cross US$ 1.2 billion by 2033

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:          

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogsYouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these